Focus Partners Wealth
COCH icon

Focus Partners Wealth’s Envoy Medical COCH Stock Holding History

Focus Partners Wealth’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
425,310
+212,655
+100% +$144K ﹤0.01% 2199
2026
Q1 		$141K Hold
212,655
– – ﹤0.01% 2471
2025
Q4 		$141K Hold
212,655
– – ﹤0.01% 2506
2025
Q3 		$165K Hold
212,655
– – ﹤0.01% 2079
2025
Q2 		$302K Hold
212,655
– – ﹤0.01% 1673
2025
Q1 		$276K Buy
212,655
+115,685
+119% +$170K ﹤0.01% 1617
2024
Q4 		$139K Buy
+96,970
New +$220K ﹤0.01% 1771

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Focus Partners Wealth's COCH Position: Q2 2026 in Review

Focus Partners Wealth increased its Envoy Medical (COCH) stake by 100% in Q2 2026, buying an estimated $144K and bringing the position to 425,310 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Focus Partners Wealth first reported a position in COCH in Q4 2024 and has held it in 7 quarters since. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Focus Partners Wealth held 425,310 shares of Envoy Medical worth $337K as of Q2 2026.
  • Focus Partners Wealth bought 212,655 Envoy Medical shares in Q2 2026, an estimated $144K.
  • Envoy Medical made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2199 holding.
  • Focus Partners Wealth first reported a position in Envoy Medical in Q4 2024 and has held it in 7 quarters since.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.